Web9 apr. 2010 · Several recent small retrospective and uncontrolled prospective studies of patients with scleroderma and patients with other miscellaneous connective tissue … WebAn aetiology-based classification of ILD appears to be very useful for diseases that are managed by removing the underlying cause or treating the underlying cause directly. However, it fails to identify idiopathic ILD. Another complementary approach to ILD classification is based on disease behaviour.
Recent advances in the treatment of systemic sclerosis associated ...
Web24 feb. 2016 · The lung is a common site of complications of systemic connective tissue disease (CTD), and lung involvement can present in several ways. Interstitial lung … Web1 mei 2013 · Mycophenolate mofetil (MMF) is an immunosuppressive medication that is gaining popularity as an alternative to CYC for the treatment of CTD-ILD. Over the last 6 … cookin up in the lab like i\u0027m rick and morty
National Center for Biotechnology Information
WebSystemic sclerosis-interstitial lung disease (SSc-ILD) is a major complication of SSc resulting in important morbidity and mortality. Next to cyclophosphamide and mycophenolate mofetil, tocilizumab and nintedanib have proven efficacy in the treatment of SSc-ILD. The highly variable course of SSc-ILD … Web(CTDs) describe treatment of ILD with mycophenolate mofetil (MMF), an immunosuppressive agent with a rela-tively favorable safety profile. We add to the current liter-ature with this case series of 4 patients with dermatomy-ositis (1 with skin disease and symptomatic muscle disease, 1 with skin disease and subclinical muscle dis- WebALMS trial: Mycophenelate mofetil vs cyclophosphamide for lupus nephritis ALMS-2 trial: Mycophenelate mofetil vs azathioprine for lupus nephritis Rheumatoid Arthritis Infliximab and methotrexate for RA BeSt trial: Early combination therapy for RA Rituximab for RA Vasculitis Azathioprine vs cyclophosphamide for ANCA vasculitis family guy season 5 imdb